Litigation Details for WILSON v. FOAMIX PHARMACEUTICALS LTD. (D.N.J. 2019)
✉ Email this page to a colleague
WILSON v. FOAMIX PHARMACEUTICALS LTD. (D.N.J. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-12-18 |
Court | District Court, D. New Jersey | Date Terminated | 2020-03-25 |
Cause | 28:1331 Fed. Question: Securities Violation | Assigned To | Michael Andre Shipp |
Jury Demand | Plaintiff | Referred To | Tonianne J. Bongiovanni |
Parties | MENLO THERAPEUTICS INC. | ||
Patents | 10,398,641 | ||
Attorneys | EVAN JASON SMITH | ||
Firms | Brodsky & Smith, LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in WILSON v. FOAMIX PHARMACEUTICALS LTD.
Details for WILSON v. FOAMIX PHARMACEUTICALS LTD. (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2019-12-17 | 1 | Complaint | announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,398,641, covering a method …This newly issued patent, which expires in September 2037, is the latest U.S. patent to be issued to the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |